Cyclophilin A and viral infections

Biochemical and Biophysical Research Communications

Volumn 424, Issue 4, 2012, Pages 647-650

  Zhou, Daijun ^a   Mei, Qiang ^a   Li, Jintao ^a   He, Haiyang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cyclophilin A; IFN ; Viral infection

Indexed keywords

CD147 ANTIGEN; CYCLOPHILIN A; INTERFERON;

HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFLUENZA; INFLUENZA VIRUS A; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; VIRUS INFECTION; VIRUS REPLICATION;

CYCLOPHILIN A; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; INTERFERON TYPE I; VIRUS DISEASES; VIRUS REPLICATION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA A VIRUS; ROTAVIRUS;

EID: 84864800554     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.07.024     Document Type: Short Survey

References (61)

1. Castro A.P.V., Carvalho T.M.U., Moussatche N., Damaso C.R.A. Redistribution of cyclophilin A to viral factories during vaccinia virus infection and its incorporation into mature particles. J. Virol. 2003, 77:9052.
2. Lammers M., Neumann H., Chin J.W., James L.C. Acetylation regulates Cyclophilin A catalysis, immunosuppression and HIV isomerization. Nat. Chem. Biol. 2010, 6:331-337.
3. Guba M., Graeb C., Jauch K.W., Geissler E.K. Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation 2004, 77:1777.
4. Wang P., Heitman J. The cyclophilins. Genome Biol. 2005, 6:226.
5. Colgan J., Asmal M., Yu B., Luban J. Cyclophilin A-deficient mice are resistant to immunosuppression by cyclosporine. J. Immunol. 2005, 174:6030.
6. Brazin K.N., Mallis R.J., Fulton D.B., Andreotti A.H. Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A. Proc. Natl. Acad. Sci. USA 2002, 99:1899-1904.
7. Hamelberg D., McCammon J.A. Mechanistic insight into the role of transition-state stabilization in cyclophilin A. J. Am. Chem. Soc. 2009, 131:147-152.
8. Watashi K., Shimotohno K. Cyclophilin and viruses: cyclophilin as a cofactor for viral infection and possible anti-viral target. Drug Target Insights 2007, 2:9-18.
9. Satoh K., Shimokawa H., Berk B.C. Cyclophilin A: promising new target in cardiovascular therapy. Circ. J. 2010, 74:2249-2256.
10. S. Obchoei, S. Wongkhan, C. Wongkham, M. Li, Q. Yao, C. Chen, Cyclophilin A: potential functions and therapeutic target for human cancer, Med. Sci. Monit. 15 (2009) RA221-RA232.
11. Liu X., Sun L., Yu M., Wang Z., Xu C., Xue Q., Zhang K., Ye X., Kitamura Y., Liu W. Cyclophilin A interacts with influenza A virus M1 protein and impairs the early stage of the viral replication. Cell. Microbiol. 2009, 11:730-741.
12. Liu X., Zhao Z., Xu C., Sun L., Chen J., Zhang L., Liu W. Cyclophilin A restricts influenza A virus replication through degradation of the M1 protein. PLoS One 2012, 7:e31063.
13. An P., Wang L.H., Hutcheson-Dilks H., Nelson G., Donfield S., Goedert J.J., Rinaldo C.R., Buchbinder S., Kirk G.D., O'Brien S.J. Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDS. PLoS Pathog. 2007, 3:e88.
14. Rits M.A.N., van Dort K.A., Kootstra N.A. Polymorphisms in the regulatory region of the cyclophilin A gene influence the susceptibility for HIV-1 infection. PLoS One 2008, 3:e3975.
15. Braaten D., Luban J. Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells. EMBO J. 2001, 20:1300-1309.
16. An P., Wang L.H., Hutcheson-Dilks H., Nelson G., Donfield S., Goedert J.J., Rinaldo C.R., Buchbinder S., Kirk G.D., O'Brien S.J., Winkler C.A. Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDS. PLoS Pathog. 2007, 3:e88.
17. Luban J. Absconding with the chaperone: essential cyclophilin-Gag interaction in HIV-1 virions. Cell 1996, 87:1157-1159.
18. Bosco D.A., Eisenmesser E.Z., Pochapsky S., Sundquist W.I., Kern D. Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A. Proc. Natl. Acad. Sci. USA 2002, 99:5247-5252.
19. Takeuchi H. Contribution of Cyclophilin A to determination of simian immunodeficiency virus tropism: a progress update. Vaccine 2010, 28 (2009):B51-B54.
20. Planelles V., Benichou S. Vpr and its interactions with cellular proteins. Curr. Top. Microbiol. Immunol. 2009, 339:177-200.
21. Bruns K., Fossen T., Wray V., Henklein P., Tessmer U., Schubert U. Structural characterization of the HIV-1 Vpr N terminus: evidence of cis/trans-proline isomerism. J. Biol. Chem. 2003, 278:43188-43201.
22. Zander K., Sherman M.P., Tessmer U., Bruns K., Wray V., Prechtel A.T., Schubert E., Henklein P., Luban J., Neidleman J., Greene W.C., Schubert U. Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression. J. Biol. Chem. 2003, 278:43202-43213.
23. Ardon O., Zimmerman E.S., Andersen J.L., DeHart J.L., Blackett J., Planelles V. Induction of G2 arrest and binding to cyclophilin A are independent phenotypes of human immunodeficiency virus type 1 Vpr. J. Virol. 2006, 80:3694-3700.
24. Aiken C. Mechanistic independence of Nef and cyclophilin A enhancement of human immunodeficiency virus type 1 infectivity. Virology 1998, 248:139-147.
25. Qi M., Aiken C. Nef enhances HIV-1 infectivity via association with the virus assembly complex. Virology 2008, 373:287-297.
26. Damsker J.M., Bukrinsky M.I., Constant S.L. Preferential chemotaxis of activated human CD4+ T cells by extracellular cyclophilin A. J. Leukoc. Biol. 2007, 82:613.
27. Yurchenko V., Constant S., Bukrinsky M. Dealing with the family: CD147 interactions with cyclophilins. Immunology 2006, 117:301-309.
28. Pushkarsky T., Zybarth G., Dubrovsky L., Yurchenko V., Tang H., Guo H., Toole B., Sherry B., Bukrinsky M. CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A. Proc. Nat. Acad. Sci. USA 2001, 98:6360.
29. Luban J., Bossolt K.L., Franke E.K., Kalpana G.V., Goff S.P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 1993, 73:1067-1078.
30. Saphire A.C., Bobardt M.D., Gallay P.A. Host cyclophilin A mediates HIV-1 attachment to target cells via heparans. EMBO J. 1999, 18:6771-6785.
31. Pushkarsky T., Yurchenko V., Laborico A., Bukrinsky M. CD147 stimulates HIV-1 infection in a signal-independent fashion. Biochem. Biophys. Res. Commun. 2007, 363:495-499.
32. Chatterji U., Bobardt M., Selvarajah S., Yang F., Tang H., Sakamoto N., Vuagniaux G., Parkinson T., Gallay P. The isomerase active site of cyclophilin A is critical for hepatitis C virus replication. J. Biol. Chem. 2009, 284:16998.
33. Fischer G., Gallay P., Hopkins S. Cyclophilin inhibitors for the treatment of HCV infection. Curr. Opin. Investig. Drugs 2010, 11:911.
34. Liu Z., Yang F., Robotham J.M., Tang H. Critical role of cyclophilin A and its prolyl-peptidyl isomerase activity in the structure and function of the hepatitis C virus replication complex. J. Virol. 2009, 83:6554.
35. Penin F., Brass V., Appel N., Ramboarina S., Montserret R., Ficheux D., Blum H.E., Bartenschlager R., Moradpour D. Structure and function of the membrane anchor domain of hepatitis C virus nonstructural protein 5A. J. Biol. Chem. 2004, 279:40835.
36. Hanoulle X., Badillo A., Wieruszeski J.M., Verdegem D., Landrieu I., Bartenschlager R., Penin F., Lippens G. Hepatitis C virus NS5A protein is a substrate for the peptidyl-prolyl cis/trans isomerase activity of cyclophilins A and B. J. Biol. Chem. 2009, 284:13589.
37. Tellinghuisen T.L., Foss K.L., Treadaway J.C., Rice C.M. Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein. J. Virol. 2008, 82:1073.
38. Verdegem D., Badillo A., Wieruszeski J.M., Landrieu I., Leroy A., Bartenschlager R., Penin F., Lippens G., Hanoulle X. Domain 3 of NS5A protein from the hepatitis C virus has intrinsic {alpha}-helical propensity and is a substrate of cyclophilin A. J. Biol. Chem. 2011, 286:20441-20454.
39. Smart E.J., De Rose R.A., Farber S.A. Annexin 2-caveolin 1 complex is a target of ezetimibe and regulates intestinal cholesterol transport. Proc. Natl. Acad. Sci. USA 2004, 101:3450-3455.
40. Gaither L.A., Borawski J., Anderson L.J., Balabanis K.A., Devay P., Joberty G., Rau C., Schirle M., Bouwmeester T., Mickanin C., Zhao S., Vickers C., Lee L., Deng G., Baryza J., Fujimoto R.A., Lin K., Compton T., Wiedmann B. Multiple cyclophilins involved in different cellular pathways mediate HCV replication. Virology 2010, 397:43-55.
41. M. Arévalo-Rodríguez, M.E. Cardenas, X. Wu, S.D. Hanes, J. Heitman, Cyclophilin A and Ess1 interact with and regulate silencing by the Sin3-CRpd3 histone deacetylase, EMBO J. 19 (2000) 3739-3749.
42. Pal S., Yun R., Datta A., Lacomis L., Erdjument-Bromage H., Kumar J., Tempst P., Sif S. MSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad. Mol. Cell. Biol. 2003, 23:7475.
43. Stuyver L.J., McBrayer T.R., Tharnish P.M., Hassan A.E.A., Chu C.K., Pankiewicz K.W., Watanabe K.A., Schinazi R.F., Otto M.J. Dynamics of subgenomic hepatitis C virus replicon RNA levels in Huh-7 cells after exposure to nucleoside antimetabolites. J. Virol. 2003, 77:10689.
44. Locarnini S., McMillan J., Bartholomeusz A. The hepatitis B virus and common mutants 2003, 5-16.
45. Xie Y., Zhai J., Deng Q., Tiollais P., Wang Y., Zhao M. Entry of hepatitis B virus: mechanism and new therapeutic target. Pathol. Biol. (Paris) 2010, 58:301-307.
46. Tian X., Zhao C., Zhu H., She W., Zhang J., Liu J., Li L., Zheng S., Wen Y.M., Xie Y. Hepatitis B virus (HBV) surface antigen interacts with and promotes cyclophilin A secretion: possible link to pathogenesis of HBV infection. J. Virol. 2010, 84:3373.
47. Patient R., Hourioux C., Sizaret P.Y., Trassard S., Sureau C., Roingeard P. Hepatitis B virus subviral envelope particle morphogenesis and intracellular trafficking. J. Virol. 2007, 81:3842.
48. Arora K., Gwinn W.M., Bower M.A., Watson A., Okwumabua I., MacDonald H.R., Bukrinsky M.I., Constant S.L. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J. Immunol. 2005, 175:517.
49. Zhao C., Fang C.Y., Tian X.C., Wang L., Yang P.Y., Wen Y.M. Proteomic analysis of hepatitis B surface antigen positive transgenic mouse liver and decrease of cyclophilin A. J. Med. Virol. 2007, 79:1478-1484.
50. Liu T., Ye Z. Restriction of viral replication by mutation of the influenza virus matrix protein. J. Virol. 2002, 76:13055.
51. Watanabe K., Fuse T., Asano I., Tsukahara F., Maru Y., Nagata K., Kitazato K., Kobayashi N. Identification of Hsc70 as an influenza virus matrix protein (M1) binding factor involved in the virus life cycle. FEBS Lett. 2006, 580:5785-5790.
52. Shaw M.L., Stone K.L., Colangelo C.M., Gulcicek E.E., Palese P. Cellular proteins in influenza virus particles. PLoS Pathog. 2008, 4:e1000085.
53. Liu N., Song W., Wang P., Lee K., Chan W., Chen H., Cai Z. Proteomics analysis of differential expression of cellular proteins in response to avian H9N2 virus infection in human cells. Proteomics 2008, 8:1851-1858.
54. Liu X., Sun L., Yu M., Wang Z., Xu C., Xue Q., Zhang K., Ye X., Kitamura Y., Liu W. Cyclophilin A interacts with influenza A virus M1 protein and impairs the early stage of the viral replication. Cell. Microbiol. 2009, 11:730-741.
55. Watanabe A., Yoneda M., Ikeda F., Terao-Muto Y., Sato H., Kai C. CD147/EMMPRIN acts as a functional entry receptor for measles virus on epithelial cells. J. Virol. 2010, 84:4183.
56. Bose S., Mathur M., Bates P., Joshi N., Banerjee A.K. Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype. J. Gen. Virol. 2003, 84:1687.
57. Luo C., Luo H., Zheng S., Gui C., Yue L., Yu C., Sun T., He P., Chen J., Shen J. Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A. Biochem. Biophys. Res. Commun. 2004, 321:557-565.
58. Chen Z., Mi L., Xu J., Yu J., Wang X., Jiang J., Xing J., Shang P., Qian A., Li Y. Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus. J. Infect. Dis. 2005, 191:755.
59. Takeuchi H., Buckler-White A., Goila-Gaur R., Miyagi E., Khan M.A., Opi S., Kao S., Sokolskaja E., Pertel T., Luban J. Vif counteracts a cyclophilin A-imposed inhibition of simian immunodeficiency viruses in human cells. J. Virol. 2007, 81:8080.
60. Manel N., Hogstad B., Wang Y., Levy D.E., Unutmaz D., Littman D.R. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 2010, 467:214-217.
61. He H., Zhou D., Fan W., Fu X., Zhang J., Shen Z., Li J., Wu Y. Cyclophilin A inhibits rotavirus replication by facilitating host IFN-I production. Biochem. Biophys. Res. Commun. 2012, 422:664-669.